Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
0.8220
-0.0730 (-8.16%)
At close: Oct 22, 2026, 4:00 PM EDT
0.8399
+0.0179 (2.18%)
After-hours: Oct 22, 2026, 4:56 PM EDT
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $87.88 million as of October 22, 2026. Its market cap has decreased by 60.24% in one year.
Market Cap
87.88M
Enterprise Value
45.46M
1-Year Change
-60.24%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since the IPO on July 2, 2021, Nyxoah's market cap has decreased from $746.03M to $87.88M, a decrease of -88.22%. That is a compound annual growth rate of -33.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 87.88M | -57.42% |
| Dec 31, 2025 | 206.37M | -35.52% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | -26.92% |
| Jul 2, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MaxCyte | 134.17M |
| Quanterix | 131.00M |
| Owlet | 121.56M |
| Apyx Medical | 101.94M |
| Hyperfine | 82.42M |
| Sera Prognostics | 80.08M |
| Pulmonx | 75.16M |
| Lucid Diagnostics | 72.06M |